Z-338

Phase 2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Functioanl Dyspepsia

Conditions

Functioanl Dyspepsia

Trial Timeline

Apr 1, 2007 → Jul 1, 2010

NCT ID

NCT00458328

About Z-338

Z-338 is a phase 2 stage product being developed by Zeria Pharmaceutical for Functioanl Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT00458328. Target conditions include Functioanl Dyspepsia.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (5)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01973790	Phase 3	Completed	Mar 1, 2014	Apr 1, 2017	Dyspepsia
NCT00458328	Phase 2	Completed	Apr 1, 2007	Jul 1, 2010	Functioanl Dyspepsia
NCT00333372	Phase 2	Completed	Apr 1, 2006	—	Functional Dyspepsia
NCT00323817	Phase 2	Completed	Apr 1, 2006	Oct 1, 2009	Functional Dyspepsia
NCT00298194	Phase 2	Completed	Feb 1, 2006	—	Dyspepsia

Other Products from Zeria Pharmaceutical

Z-338Phase 3

Z-100 + PlaceboPhase 3

Z-213 + Saccharated Ferric OxidePhase 3

Z-213Phase 3

Z-521Phase 3